Skip to main content

Table 2 Univariate and multivariate Cox hazards analysis between clinical features and OS

From: Development and validation of a prognostic nomogram in gastric cancer with hepatitis B virus infection

Characteristics Univariate analysis Multivariate analysis
HR (95% CI) P-value HR (95% CI) P-value
Age, year 2.197 (1.177–4.101) 0.013 2.278 (1.172–4.428) 0.015
Sex
 Male/female 0.848 (0.503–1.429) 0.535   
TNM stage
 I/II/III/IV 3.135 (2.280–4.310) < 0.001   
Tumor stage
 T1/T2/T3/T4 1.481 (1.074–2.043) 0.017 1.801 (1.293–2.510) 0.001
Node stage
 N0/N1/N2/N3 1.317 (1.019–1.701) 0.035   
Metastasis
 No/yes 4.753 (2.732–8.268) < 0.001 5.164 (2.912–9.157) < 0.001
Location
 1/2/3/4 0.958 (0.732–1.254) 0.757   
AST, U/L
 ≤ 22.8/> 22.8 1.511 (0.934–2.446) 0.093   
ALT, U/L
 ≤ 30.1/> 30.1 0.558 (0.267–1.168) 0.122   
LDH, U/L
 ≤ 168.7/> 168.7 2.026 (1.252–3.281) 0.004   
GGT, U/L
 ≤ 26.9/> 26.9 3.157 (1.929–5.167) 0.001 2.093 (1.223–3.581) 0.007
TBA, μmol/L
 ≤ 5.4/> 5.4 2.065 (1.277–3.339) 0.003   
ALP, U/L
 ≤ 80/> 80 3.393 (2.093–5.499) < 0.001 2.161 (1.271–3.672) 0.004
ALB, g/L
 ≤ 38.8/> 38.8 0.541 (0.316–0.837) 0.007   
TBIL, μmol/L
 ≤ 7.3/> 7.3 0.623 (0.369–1.053) 0.077   
ApoA1, g/L
 ≤ 1.1/> 1.1 0.564 (0.243–1.309) 0.182   
ApoB, g/L
 ≤ 1.1/> 1.1 2.056 (1.101–3.841) 0.024   
PT, S
 ≤ 11.9/> 11.9 1.464 (0.886–2.419) 0.137   
Fbg, g/L
 ≤ 3.6/> 3.6 1.876 (1.052–3.346) 0.033